SCHEMBL9448327

SCHEMBL9448327

COc1ccc2c(c1)CCC1C(Cc3ccccc3)NCCC21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 1/20 0.48
▸ LMNA P02545 4/20 0.45
▸ MAPT P10636 2/20 0.45
▸ HSD17B1 P14061 2/20 0.45
▸ RECQL P46063 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.44
▸ GRIN2B Q13224 4/20 0.43
▸ GRIN1 Q05586 1/20 0.43
▸ SIGMAR1 Q99720 2/20 0.43
▸ HTR1A P08908 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ CYP19A1 P11511 2/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ ESR1 P03372 1/20 0.41
▸ NR3C1 P04150 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9448043 0.90 NPY5R (0.48) NPY5RLMNAMAPTHSD17B1RECQL
SCHEMBL9448048 0.90 NPY5R (0.48) NPY5RLMNAMAPTHSD17B1RECQL
Hydrochloric Acid SCHEMBL9448267 0.89 NPY5R (0.48) NPY5RLMNAMAPTHSD17B1RECQL
SCHEMBL9448182 0.84 NPY5R (0.46) NPY5RLMNAMAPTHSD17B1RECQL
SCHEMBL9448186 0.84 NPY5R (0.46) NPY5RLMNAMAPTHSD17B1RECQL
SCHEMBL9447972 0.83 EED (0.46) NPY5RLMNAMAPTHSD17B1RECQL
SCHEMBL9448102 0.82 PRCP (0.51) SIGMAR1
SCHEMBL9448423 0.81 NPY5R (0.43) NPY5RLMNAMAPTHSD17B1RECQL
SCHEMBL9448134 0.80 LMNA (0.41) NPY5RLMNAMAPTHSD17B1RECQL
SCHEMBL9448094 0.80 LMNA (0.41) NPY5RLMNAMAPTHSD17B1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5248677-A Nervous system disorders or antidepressants ABBOTT LABORATORIES (US) 1993-09-28 — — US disclosed
US-5180733-A Antidepressants or nervous systen disorders ABBOTT LABORATORIES (US) 1993-01-19 — — US disclosed
EP-0461353-A1 Biogenic amine uptake inhibitors ABBOTT LABORATORIES (US) 1991-12-18 — — EP disclosed
Send feedback